<DOC>
	<DOCNO>NCT00282412</DOCNO>
	<brief_summary>Rheumatoid arthritis disease believe due immune cell , cell normally protect body causing damage body . Risk death high people twenty joint actively involved disease , positive rheumatoid factor , elevate sedimentation rate ( laboratory measure active inflammation ) , patient limitation daily activity ( trouble simple thing like open carton milk ) . In high risk patient , life significantly shorten . Death usually heart disease , kidney failure , neck dislocation , broken hip bone , blood clot lung . In study use moderate dose chemotherapy ( cyclophosphamide fludarabine ) CAMPATH-1H ( protein kill immune cell think cause disease ) , follow infusion blood stem cell collect patient 's brother sister ( allogeneic stem cell transplant ) . The purpose moderate dose chemotherapy CAMPATH-1H destroy cell immune system allow cell patient 's brother sister grow . The purpose stem cell infusion restore blood cell production , severely impaired moderate dose chemotherapy CAMPATH-1H , produce normal immune system longer attack body .</brief_summary>
	<brief_title>Rheumatoid Arthritis : Tolerance Induction Mixed Chimerism</brief_title>
	<detailed_description>Peripheral blood stem cell mobilization ( PBSC ) PBSC mobilize G-CSF ( dose may adjust 5-10 ug/kg/day PI toxicity , e.g . flu-like symptom ) stem cell collection begin day 4 5 . Leukapheresis may repeat four consecutive day . Conditioning Regimen Immune Ablation : Fludarabine 25 mg/m2/d x 5 day ( dosage base adjust body weight ) give IV 30 minute 100 cc normal saline . Cyclophosphamide 50 mg/kg/d x 4 day ( dosage base adjust body weight ) give IV 1 hour 500 cc normal saline . CAMPATH-1H 30 mg/day x 3 day ( dose adjustment ) give IV 2 hour 100 cc normal saline . Premedication acetaminophen 650mg &amp; benadryl 25-50mg PO/IV give 30-60min infusion . These medication repeat need . Hydration approximately 200 cc /hour begin 6 hour cyclophosphamide continue 24 hour last cyclophosphamide dose . G-CSF continue absolute neutrophil count reach 1,000 cells/ml three day . Cyclosporine start 200 mg po BID adjust HPLC level 150-250 toxicity ( e.g . tremor , renal insufficiency , TTP , etc. ) . CSA continue 6 month unless stop toxicity Mycophenolate Mofetil ( Cellcept ) give 1 gram po BID may adjust toxicity ( e.g . cytopenia ) . Cellcept continue 6 month unless stop toxicity .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Participant Age &gt; 18 &lt; 60 year time pretransplant evaluation . An established clinical diagnosis rheumatoid arthritis American College Rheumatology criterion . Patients must fail autologous hematopoietic transplant fail respond either methotrexate leflunomide combination TNF inhibitor . Failure define inability tolerate treatment least 6 swollen joint 20 involved joint inability answer least 70 % HAQ question `` difficulty '' despite 2 month treatment . Ability give inform consent . Patient must HLA match sibling donor A , B , C , DR loci proceed HLA match cord blood donor . If donor HLA match cord blood , cord blood stem cell obtain NMDP ( 18005481375 ) one two unit HLA match cord blood infused day zero . Participant Exclusion Criteria History coronary artery disease , document congestive heart failure . HIV positive . Uncontrolled diabetes mellitus , illness opinion investigator would jeopardize ability patient tolerate aggressive chemoradiotherapy . Prior history malignancy except localize basal cell squamous skin cancer . Other malignancy patient judge cured local surgical therapy , head neck cancer , stage I breast cancer consider individual basis . Positive pregnancy test , inability unwillingness pursue effective mean birth control , failure willingly accept comprehend irreversible sterility side effect therapy . Psychiatric illness mental deficiency make compliance treatment inform consent impossible . FEV1/FVC &lt; 70 % predict , DLCO &lt; 40 % predict . Resting LVEF &lt; 45 % . Bilirubin &gt; 2.0 mg/dl ( unless due Gilberts ) , transferase ( AST ) &gt; 2.5 x upper limit normal . Serum creatinine &gt; 2.0 mg/dl . Donor Exclusion Criteria Age &lt; 18 year . Positive HIV1 , HIV2 , HTLVI , HTLVII . Active hepatitis B C. History malignancy except localized cancer skin cancer deem cured . History myocardial infarction congestive heart failure . Inability give inform consent . Current pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>